DMD and Duchenne muscular dystrophy: Gene therapy has the potential to correct or improve disease in DMD and BMD, but the size of the dystrophin ORF makes this challenging since it exceeds the packaging capacities of favoured viral vectors, such as AAV and lentivirus vectors24, 25.